RB N Stock Overview
Manufactures and sells health, hygiene, and nutrition products in the United Kingdom and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 3/6 |
| Past Performance | 1/6 |
| Financial Health | 2/6 |
| Dividends | 4/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
Reckitt Benckiser Group plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£1,286.07 |
| 52 Week High | UK£1,343.53 |
| 52 Week Low | UK£962.38 |
| Beta | 0.17 |
| 1 Month Change | -4.28% |
| 3 Month Change | -4.28% |
| 1 Year Change | 37.52% |
| 3 Year Change | n/a |
| 5 Year Change | -34.20% |
| Change since IPO | -6.52% |
Recent News & Updates
Recent updates
Shareholder Returns
| RB N | MX Household Products | MX Market | |
|---|---|---|---|
| 7D | 0% | -0.1% | -1.9% |
| 1Y | 37.5% | -3.0% | -4.9% |
Return vs Industry: RB N exceeded the MX Household Products industry which returned -3% over the past year.
Return vs Market: RB N exceeded the MX Market which returned -4.9% over the past year.
Price Volatility
| RB N volatility | |
|---|---|
| RB N Average Weekly Movement | n/a |
| Household Products Industry Average Movement | 5.3% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in MX Market | 8.9% |
| 10% least volatile stocks in MX Market | 2.7% |
Stable Share Price: RB N's share price has been volatile over the past 3 months compared to the MX market.
Volatility Over Time: Insufficient data to determine RB N's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1819 | 37,900 | Kris Licht | www.reckitt.com |
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products in the United Kingdom and internationally. The company offers germ protection under Dettol name; intimate wellness under Durex and KY brand names; over the counter under the Biofreeze, Gaviscon, Mucinex, Nurofen, and Strepsils names. It also provides personal care products under Clearasil and Veet brand names; vitamins, minerals, and supplements under Airborne, Movefree, and neuriva names; and disinfectant products under the Finish, Harpic, and Lysol brands.
Reckitt Benckiser Group plc Fundamentals Summary
| RB N fundamental statistics | |
|---|---|
| Market cap | Mex$883.16b |
| Earnings (TTM) | Mex$37.25b |
| Revenue (TTM) | Mex$369.12b |
23.7x
P/E Ratio2.4x
P/S RatioIs RB N overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| RB N income statement (TTM) | |
|---|---|
| Revenue | UK£14.17b |
| Cost of Revenue | UK£5.57b |
| Gross Profit | UK£8.60b |
| Other Expenses | UK£7.17b |
| Earnings | UK£1.43b |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
Jul 24, 2025
| Earnings per share (EPS) | 2.10 |
| Gross Margin | 60.66% |
| Net Profit Margin | 10.09% |
| Debt/Equity Ratio | 126.9% |
How did RB N perform over the long term?
See historical performance and comparisonDividends
4.1%
Current Dividend Yield99%
Payout RatioDoes RB N pay a reliable dividends?
See RB N dividend history and benchmarks| Reckitt Benckiser Group dividend dates | |
|---|---|
| Ex Dividend Date | Apr 10 2025 |
| Dividend Pay Date | May 29 2025 |
| Days until Ex dividend | 26 days |
| Days until Dividend pay date | 23 days |
Does RB N pay a reliable dividends?
See RB N dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/05 15:17 |
| End of Day Share Price | 2025/04/09 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Reckitt Benckiser Group plc is covered by 54 analysts. 16 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Pedro Gil Garcia Alejo | Banco Santander |
| Susanne Seibel | Barclays |
| Iain Simpson | Barclays |